Sponsor

Cns Pharmaceuticals Inc.

United States 2100 West Loop South Suite 900, 77027-3522, United States

About the sponsor

Cns Pharmaceuticals Inc. focuses its clinical research on glioblastoma multiforme, with attention to adult patients whose disease has recurred or progressed after initial treatment.

Recurrent glioblastoma
Progressive brain tumours
Adult neuro-oncology

The sponsor’s activity is centered on treatment options for aggressive central nervous system malignancies in the oncology setting.

About Specializations

Cns Pharmaceuticals Inc. runs clinical trials in conditions such as Glioblastoma multiforme, among others.

Glioblastoma multiforme

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

1 clinical trial

Glioblastoma multiforme

Not recruiting

Registered drugNo placebo

Study of Berubicin versus Lomustine in adult patients with recurrent Glioblastoma Multiforme after first-line treatment failure

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Lomustine
Sponsor:Cns Pharmaceuticals Inc.

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →